

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.44223681 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.27752391 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.27752391 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.14091901 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.95613505 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.87878276 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.79485941 |
| 8 | regulation of T cell tolerance induction (GO:0002664) | 4.59824163 |
| 9 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.44480419 |
| 10 | cellular response to type I interferon (GO:0071357) | 4.42270916 |
| 11 | type I interferon signaling pathway (GO:0060337) | 4.42270916 |
| 12 | response to type I interferon (GO:0034340) | 4.38968300 |
| 13 | negative regulation of interleukin-12 production (GO:0032695) | 4.25857218 |
| 14 | immunoglobulin mediated immune response (GO:0016064) | 4.13083833 |
| 15 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.11632884 |
| 16 | regulation of tolerance induction (GO:0002643) | 4.08996738 |
| 17 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.04651881 |
| 18 | regulation of gamma-delta T cell activation (GO:0046643) | 4.00738142 |
| 19 | detection of other organism (GO:0098543) | 3.97781075 |
| 20 | positive regulation by symbiont of host defense response (GO:0052509) | 3.96496945 |
| 21 | modulation by symbiont of host defense response (GO:0052031) | 3.96496945 |
| 22 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.96496945 |
| 23 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.96496945 |
| 24 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.96496945 |
| 25 | modulation by symbiont of host immune response (GO:0052553) | 3.96496945 |
| 26 | positive regulation of type 2 immune response (GO:0002830) | 3.96479101 |
| 27 | positive regulation of tolerance induction (GO:0002645) | 3.95657125 |
| 28 | T cell migration (GO:0072678) | 3.90917793 |
| 29 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.89000850 |
| 30 | detection of bacterium (GO:0016045) | 3.82374869 |
| 31 | regulation of antigen processing and presentation (GO:0002577) | 3.73486750 |
| 32 | macrophage activation involved in immune response (GO:0002281) | 3.72947569 |
| 33 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.71774460 |
| 34 | positive regulation of antigen processing and presentation (GO:0002579) | 3.68727680 |
| 35 | response to peptidoglycan (GO:0032494) | 3.63565268 |
| 36 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.60049962 |
| 37 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.57685798 |
| 38 | neutrophil activation involved in immune response (GO:0002283) | 3.50817973 |
| 39 | NIK/NF-kappaB signaling (GO:0038061) | 3.42961816 |
| 40 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.36794222 |
| 41 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.34385931 |
| 42 | regulation of regulatory T cell differentiation (GO:0045589) | 3.33758578 |
| 43 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.32062001 |
| 44 | negative regulation of T cell mediated immunity (GO:0002710) | 3.31844696 |
| 45 | detection of external biotic stimulus (GO:0098581) | 3.29468645 |
| 46 | T-helper 1 type immune response (GO:0042088) | 3.25127643 |
| 47 | negative thymic T cell selection (GO:0045060) | 3.23617825 |
| 48 | B cell mediated immunity (GO:0019724) | 3.22723038 |
| 49 | negative T cell selection (GO:0043383) | 3.21484058 |
| 50 | lymphocyte chemotaxis (GO:0048247) | 3.19187524 |
| 51 | regulation of type 2 immune response (GO:0002828) | 3.14724615 |
| 52 | negative regulation of innate immune response (GO:0045824) | 3.14574343 |
| 53 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.14550444 |
| 54 | regulation of interferon-alpha production (GO:0032647) | 3.14285225 |
| 55 | defense response to protozoan (GO:0042832) | 3.14231247 |
| 56 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.13386270 |
| 57 | cellular response to interferon-gamma (GO:0071346) | 3.13169329 |
| 58 | myeloid dendritic cell differentiation (GO:0043011) | 3.11746966 |
| 59 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.11113283 |
| 60 | positive thymic T cell selection (GO:0045059) | 3.10231890 |
| 61 | detection of molecule of bacterial origin (GO:0032490) | 3.09092752 |
| 62 | regulation of interleukin-12 production (GO:0032655) | 3.08234484 |
| 63 | positive regulation of interferon-alpha production (GO:0032727) | 3.07933685 |
| 64 | regulation of chronic inflammatory response (GO:0002676) | 3.06779951 |
| 65 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.04777997 |
| 66 | response to interferon-gamma (GO:0034341) | 3.01010238 |
| 67 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.99801738 |
| 68 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.96867325 |
| 69 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.96439229 |
| 70 | dendritic cell chemotaxis (GO:0002407) | 2.96072047 |
| 71 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.94239459 |
| 72 | leukocyte aggregation (GO:0070486) | 2.92529968 |
| 73 | myeloid dendritic cell activation (GO:0001773) | 2.91860689 |
| 74 | response to interferon-beta (GO:0035456) | 2.91166655 |
| 75 | detection of biotic stimulus (GO:0009595) | 2.89020463 |
| 76 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.88557700 |
| 77 | germinal center formation (GO:0002467) | 2.88301325 |
| 78 | response to protozoan (GO:0001562) | 2.87385319 |
| 79 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.87192790 |
| 80 | response to muramyl dipeptide (GO:0032495) | 2.85149250 |
| 81 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.83564790 |
| 82 | negative regulation of viral genome replication (GO:0045071) | 2.82178132 |
| 83 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.81553543 |
| 84 | response to interleukin-15 (GO:0070672) | 2.79553226 |
| 85 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.79205684 |
| 86 | response to host immune response (GO:0052572) | 2.79205684 |
| 87 | T cell selection (GO:0045058) | 2.77960687 |
| 88 | positive regulation of interleukin-12 production (GO:0032735) | 2.77352915 |
| 89 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.77137920 |
| 90 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.76591810 |
| 91 | microglial cell activation (GO:0001774) | 2.75223080 |
| 92 | myeloid cell activation involved in immune response (GO:0002275) | 2.75179828 |
| 93 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.74277172 |
| 94 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.73960043 |
| 95 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.73890648 |
| 96 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.73890648 |
| 97 | regulation of T-helper cell differentiation (GO:0045622) | 2.72790094 |
| 98 | positive T cell selection (GO:0043368) | 2.72078851 |
| 99 | interferon-gamma secretion (GO:0072643) | 2.70977224 |
| 100 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.70307431 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.07439631 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.05272439 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.02350507 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.36948557 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.20265629 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.94839806 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.53124320 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.16664155 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.99973754 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.93740287 |
| 11 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.84169838 |
| 12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.74452184 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.73057124 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.71564400 |
| 15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.60725738 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.37998729 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.32731513 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.31588715 |
| 19 | MYB_26560356_Chip-Seq_TH2_Human | 2.23710246 |
| 20 | MAF_26560356_Chip-Seq_TH1_Human | 2.10031037 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.07040764 |
| 22 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.97581180 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.97147221 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.95566962 |
| 25 | GATA1_22025678_ChIP-Seq_K562_Human | 1.90093013 |
| 26 | SPI1_23127762_ChIP-Seq_K562_Human | 1.89761617 |
| 27 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.87126981 |
| 28 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.86910474 |
| 29 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.86663595 |
| 30 | * MYB_26560356_Chip-Seq_TH1_Human | 1.85390030 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.79476664 |
| 32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.78611100 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.76843650 |
| 34 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.74784197 |
| 35 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.74770808 |
| 36 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.69901547 |
| 37 | * SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.63740456 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.60531652 |
| 39 | MYC_22102868_ChIP-Seq_BL_Human | 1.57297505 |
| 40 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.56445593 |
| 41 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.52091687 |
| 42 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50200324 |
| 43 | MAF_26560356_Chip-Seq_TH2_Human | 1.49765252 |
| 44 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.46310055 |
| 45 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44907991 |
| 46 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.43664904 |
| 47 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42188979 |
| 48 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.41591853 |
| 49 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.35945753 |
| 50 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.33818798 |
| 51 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31003197 |
| 52 | GATA3_26560356_Chip-Seq_TH2_Human | 1.29821572 |
| 53 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.29314425 |
| 54 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.28907255 |
| 55 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.28429600 |
| 56 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26021051 |
| 57 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23498087 |
| 58 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.23003721 |
| 59 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.22949506 |
| 60 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.22751749 |
| 61 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.21666054 |
| 62 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.21638170 |
| 63 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.20244961 |
| 64 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.18664493 |
| 65 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.18460348 |
| 66 | GATA1_19941826_ChIP-Seq_K562_Human | 1.18459401 |
| 67 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.16832177 |
| 68 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.16036164 |
| 69 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12954555 |
| 70 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12937310 |
| 71 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12583762 |
| 72 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.12048538 |
| 73 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.11048587 |
| 74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10997331 |
| 75 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.10634234 |
| 76 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10129969 |
| 77 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09345376 |
| 78 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.09225085 |
| 79 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09104811 |
| 80 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08878472 |
| 81 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.05998693 |
| 82 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04874495 |
| 83 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00382719 |
| 84 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.97896239 |
| 85 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95319103 |
| 86 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.94766646 |
| 87 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.93941827 |
| 88 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.93476824 |
| 89 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.92376910 |
| 90 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88997553 |
| 91 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.87132396 |
| 92 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.86306622 |
| 93 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85899909 |
| 94 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84391960 |
| 95 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.84251085 |
| 96 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.81681419 |
| 97 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.81450581 |
| 98 | GATA2_19941826_ChIP-Seq_K562_Human | 0.78918463 |
| 99 | * STAT1_20625510_ChIP-Seq_HELA_Human | 0.78881020 |
| 100 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.78174067 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.22375411 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.18241670 |
| 3 | MP0003303_peritoneal_inflammation | 3.80110469 |
| 4 | MP0003436_decreased_susceptibility_to | 3.42088282 |
| 5 | MP0005671_abnormal_response_to | 3.32863765 |
| 6 | MP0009785_altered_susceptibility_to | 3.30262059 |
| 7 | MP0000685_abnormal_immune_system | 3.13131594 |
| 8 | MP0006082_CNS_inflammation | 3.06211804 |
| 9 | MP0005387_immune_system_phenotype | 3.06113716 |
| 10 | MP0001790_abnormal_immune_system | 3.06113716 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.99421136 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.96188356 |
| 13 | MP0001800_abnormal_humoral_immune | 2.89877877 |
| 14 | MP0005025_abnormal_response_to | 2.82611930 |
| 15 | MP0002419_abnormal_innate_immunity | 2.61331658 |
| 16 | MP0002723_abnormal_immune_serum | 2.54648327 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.49066592 |
| 18 | MP0003300_gastrointestinal_ulcer | 2.31934818 |
| 19 | MP0001819_abnormal_immune_cell | 2.25238134 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.24902326 |
| 21 | MP0003763_abnormal_thymus_physiology | 2.22071329 |
| 22 | MP0010155_abnormal_intestine_physiology | 2.15171001 |
| 23 | MP0001533_abnormal_skeleton_physiology | 1.95441712 |
| 24 | MP0001845_abnormal_inflammatory_respons | 1.88570731 |
| 25 | MP0002405_respiratory_system_inflammati | 1.88535641 |
| 26 | MP0004947_skin_inflammation | 1.85127750 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 1.84528824 |
| 28 | MP0009764_decreased_sensitivity_to | 1.78414882 |
| 29 | MP0004510_myositis | 1.76800521 |
| 30 | MP0003191_abnormal_cellular_cholesterol | 1.75867321 |
| 31 | MP0002139_abnormal_hepatobiliary_system | 1.73188659 |
| 32 | MP0000716_abnormal_immune_system | 1.71561112 |
| 33 | MP0005451_abnormal_body_composition | 1.70480732 |
| 34 | MP0008469_abnormal_protein_level | 1.66327992 |
| 35 | MP0002398_abnormal_bone_marrow | 1.65109115 |
| 36 | MP0002138_abnormal_hepatobiliary_system | 1.64699555 |
| 37 | MP0005464_abnormal_platelet_physiology | 1.60528438 |
| 38 | MP0002166_altered_tumor_susceptibility | 1.58553147 |
| 39 | MP0005058_abnormal_lysosome_morphology | 1.53718018 |
| 40 | MP0009840_abnormal_foam_cell | 1.49537412 |
| 41 | MP0003075_altered_response_to | 1.48429227 |
| 42 | MP0005310_abnormal_salivary_gland | 1.38329271 |
| 43 | MP0000689_abnormal_spleen_morphology | 1.37547767 |
| 44 | MP0000343_altered_response_to | 1.35341806 |
| 45 | MP0003806_abnormal_nucleotide_metabolis | 1.35281956 |
| 46 | MP0002429_abnormal_blood_cell | 1.33953493 |
| 47 | MP0002722_abnormal_immune_system | 1.32851476 |
| 48 | MP0003172_abnormal_lysosome_physiology | 1.29656567 |
| 49 | MP0003866_abnormal_defecation | 1.28759922 |
| 50 | MP0009278_abnormal_bone_marrow | 1.28312600 |
| 51 | MP0008260_abnormal_autophagy | 1.27536676 |
| 52 | MP0003448_altered_tumor_morphology | 1.26773402 |
| 53 | MP0001853_heart_inflammation | 1.26654114 |
| 54 | MP0000465_gastrointestinal_hemorrhage | 1.26449107 |
| 55 | MP0000604_amyloidosis | 1.26226342 |
| 56 | MP0000858_altered_metastatic_potential | 1.25324727 |
| 57 | MP0002998_abnormal_bone_remodeling | 1.22631711 |
| 58 | MP0005166_decreased_susceptibility_to | 1.22241556 |
| 59 | MP0001873_stomach_inflammation | 1.22084670 |
| 60 | MP0001545_abnormal_hematopoietic_system | 1.20087938 |
| 61 | MP0005397_hematopoietic_system_phenotyp | 1.20087938 |
| 62 | MP0003828_pulmonary_edema | 1.15206601 |
| 63 | MP0002933_joint_inflammation | 1.14527399 |
| 64 | MP0003690_abnormal_glial_cell | 1.13512102 |
| 65 | MP0002006_tumorigenesis | 1.08202514 |
| 66 | MP0009763_increased_sensitivity_to | 1.06158649 |
| 67 | MP0000703_abnormal_thymus_morphology | 1.05880923 |
| 68 | MP0004883_abnormal_blood_vessel | 0.98687942 |
| 69 | MP0005164_abnormal_response_to | 0.98438244 |
| 70 | MP0003183_abnormal_peptide_metabolism | 0.97612551 |
| 71 | MP0002332_abnormal_exercise_endurance | 0.93888778 |
| 72 | MP0003656_abnormal_erythrocyte_physiolo | 0.93409493 |
| 73 | MP0001851_eye_inflammation | 0.91010285 |
| 74 | MP0008004_abnormal_stomach_pH | 0.85708946 |
| 75 | MP0001663_abnormal_digestive_system | 0.85142366 |
| 76 | MP0000249_abnormal_blood_vessel | 0.84687365 |
| 77 | MP0003195_calcinosis | 0.84682245 |
| 78 | MP0002254_reproductive_system_inflammat | 0.81888961 |
| 79 | MP0002132_abnormal_respiratory_system | 0.81678243 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 0.81363330 |
| 81 | MP0005365_abnormal_bile_salt | 0.78914130 |
| 82 | MP0009765_abnormal_xenobiotic_induced | 0.78883560 |
| 83 | MP0005360_urolithiasis | 0.78096599 |
| 84 | MP0002277_abnormal_respiratory_mucosa | 0.77748087 |
| 85 | MP0005390_skeleton_phenotype | 0.74911628 |
| 86 | MP0003646_muscle_fatigue | 0.71391552 |
| 87 | MP0006054_spinal_hemorrhage | 0.71147982 |
| 88 | MP0003453_abnormal_keratinocyte_physiol | 0.70002982 |
| 89 | MP0000609_abnormal_liver_physiology | 0.69982126 |
| 90 | MP0003045_fibrosis | 0.69124903 |
| 91 | MP0008874_decreased_physiological_sensi | 0.68304964 |
| 92 | MP0003091_abnormal_cell_migration | 0.67547526 |
| 93 | MP0005319_abnormal_enzyme/_coenzyme | 0.64728060 |
| 94 | MP0004808_abnormal_hematopoietic_stem | 0.63140050 |
| 95 | MP0004130_abnormal_muscle_cell | 0.59999122 |
| 96 | MP0005535_abnormal_body_temperature | 0.59921888 |
| 97 | MP0003795_abnormal_bone_structure | 0.59397623 |
| 98 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.59218202 |
| 99 | MP0003252_abnormal_bile_duct | 0.57430696 |
| 100 | MP0009115_abnormal_fat_cell | 0.53382403 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.31222997 |
| 2 | Myositis (HP:0100614) | 5.00057941 |
| 3 | Orchitis (HP:0100796) | 4.91786842 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 4.84696625 |
| 5 | Optic neuritis (HP:0100653) | 4.84696625 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 4.79824945 |
| 7 | Recurrent abscess formation (HP:0002722) | 4.62868643 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.38609651 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.25070638 |
| 10 | Gastrointestinal infarctions (HP:0005244) | 4.23270334 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 4.14092059 |
| 12 | Stomatitis (HP:0010280) | 3.97801062 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.90691798 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.79250590 |
| 15 | Mediastinal lymphadenopathy (HP:0100721) | 3.76603830 |
| 16 | T lymphocytopenia (HP:0005403) | 3.63174991 |
| 17 | Vasculitis (HP:0002633) | 3.63062472 |
| 18 | Keratoconjunctivitis sicca (HP:0001097) | 3.55585890 |
| 19 | Meningitis (HP:0001287) | 3.55252832 |
| 20 | Abnormality of T cell number (HP:0011839) | 3.52668704 |
| 21 | Recurrent skin infections (HP:0001581) | 3.40212631 |
| 22 | Recurrent viral infections (HP:0004429) | 3.39785307 |
| 23 | Pulmonary infiltrates (HP:0002113) | 3.39427440 |
| 24 | Hemoptysis (HP:0002105) | 3.36431501 |
| 25 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.33351995 |
| 26 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.31697033 |
| 27 | Recurrent cutaneous fungal infections (HP:0011370) | 3.31697033 |
| 28 | Increased IgM level (HP:0003496) | 3.29306155 |
| 29 | Keratoconjunctivitis (HP:0001096) | 3.28459961 |
| 30 | Encephalitis (HP:0002383) | 3.21952460 |
| 31 | Increased IgE level (HP:0003212) | 3.09228041 |
| 32 | Chronic obstructive pulmonary disease (HP:0006510) | 3.07112268 |
| 33 | Obstructive lung disease (HP:0006536) | 3.07112268 |
| 34 | Abnormality of glycolipid metabolism (HP:0010969) | 3.03673221 |
| 35 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.03673221 |
| 36 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.03673221 |
| 37 | Gingivitis (HP:0000230) | 3.00731643 |
| 38 | Spontaneous hematomas (HP:0007420) | 2.98657694 |
| 39 | Autoimmune thrombocytopenia (HP:0001973) | 2.90019044 |
| 40 | Autoimmune hemolytic anemia (HP:0001890) | 2.85164617 |
| 41 | Recurrent bronchitis (HP:0002837) | 2.83916067 |
| 42 | Leukocytosis (HP:0001974) | 2.83523376 |
| 43 | Chest pain (HP:0100749) | 2.82832757 |
| 44 | Gangrene (HP:0100758) | 2.82408030 |
| 45 | Hypergammaglobulinemia (HP:0010702) | 2.75454110 |
| 46 | Colitis (HP:0002583) | 2.72565724 |
| 47 | Abnormality of T cells (HP:0002843) | 2.72441592 |
| 48 | Urticaria (HP:0001025) | 2.70670965 |
| 49 | Arterial thrombosis (HP:0004420) | 2.70458084 |
| 50 | Pulmonary embolism (HP:0002204) | 2.68916315 |
| 51 | Panhypogammaglobulinemia (HP:0003139) | 2.67257497 |
| 52 | Inflammation of the large intestine (HP:0002037) | 2.61826100 |
| 53 | Chronic otitis media (HP:0000389) | 2.61074919 |
| 54 | Amyloidosis (HP:0011034) | 2.56459413 |
| 55 | Complement deficiency (HP:0004431) | 2.54147943 |
| 56 | Pustule (HP:0200039) | 2.50405843 |
| 57 | Cellulitis (HP:0100658) | 2.50104886 |
| 58 | Gastrointestinal inflammation (HP:0004386) | 2.49315496 |
| 59 | Hematochezia (HP:0002573) | 2.49290075 |
| 60 | Gingival bleeding (HP:0000225) | 2.48379172 |
| 61 | Agammaglobulinemia (HP:0004432) | 2.48155670 |
| 62 | Anorexia (HP:0002039) | 2.47844704 |
| 63 | Granulocytopenia (HP:0001913) | 2.46462937 |
| 64 | Glomerulonephritis (HP:0000099) | 2.44359890 |
| 65 | Eosinophilia (HP:0001880) | 2.43603297 |
| 66 | Purpura (HP:0000979) | 2.42848909 |
| 67 | Dysostosis multiplex (HP:0000943) | 2.39108125 |
| 68 | Abnormality of the pleura (HP:0002103) | 2.36978876 |
| 69 | Malnutrition (HP:0004395) | 2.34643331 |
| 70 | Abnormality of complement system (HP:0005339) | 2.33966770 |
| 71 | Epistaxis (HP:0000421) | 2.33527591 |
| 72 | Joint swelling (HP:0001386) | 2.32984883 |
| 73 | Prolonged bleeding time (HP:0003010) | 2.32768000 |
| 74 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.30877761 |
| 75 | Loss of speech (HP:0002371) | 2.29446124 |
| 76 | Increased serum ferritin (HP:0003281) | 2.28449791 |
| 77 | Peritonitis (HP:0002586) | 2.25874381 |
| 78 | Gastrointestinal stroma tumor (HP:0100723) | 2.23571203 |
| 79 | Abnormality of B cell number (HP:0010975) | 2.22528528 |
| 80 | Interstitial pulmonary disease (HP:0006530) | 2.21286225 |
| 81 | Abnormality of the nasal mucosa (HP:0000433) | 2.18202236 |
| 82 | IgG deficiency (HP:0004315) | 2.17642023 |
| 83 | Lymphopenia (HP:0001888) | 2.17485966 |
| 84 | Abnormality of eosinophils (HP:0001879) | 2.14978198 |
| 85 | Premature loss of primary teeth (HP:0006323) | 2.14229493 |
| 86 | Increased cerebral lipofuscin (HP:0011813) | 2.13694691 |
| 87 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.11586868 |
| 88 | Abnormality of the endocardium (HP:0004306) | 2.09678519 |
| 89 | Polyneuropathy (HP:0001271) | 2.09065404 |
| 90 | Severe combined immunodeficiency (HP:0004430) | 2.08478604 |
| 91 | Glomerulopathy (HP:0100820) | 2.08377251 |
| 92 | Abnormality of T cell physiology (HP:0011840) | 2.07822266 |
| 93 | Osteomyelitis (HP:0002754) | 2.05883332 |
| 94 | Episodic fever (HP:0001954) | 2.05364642 |
| 95 | Nasal polyposis (HP:0100582) | 2.05297219 |
| 96 | Petechiae (HP:0000967) | 2.05242347 |
| 97 | Abnormality of iron homeostasis (HP:0011031) | 2.02599090 |
| 98 | Arthralgia (HP:0002829) | 2.00840683 |
| 99 | Abnormality of the pericardium (HP:0001697) | 1.98217867 |
| 100 | Abnormality of the peritoneum (HP:0002585) | 1.97367265 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.81805650 |
| 2 | TYK2 | 3.74842014 |
| 3 | RIPK4 | 3.45415342 |
| 4 | IKBKE | 2.80492314 |
| 5 | MAP3K14 | 2.80089138 |
| 6 | TXK | 2.77034482 |
| 7 | JAK3 | 2.74061735 |
| 8 | PRPF4B | 2.66982086 |
| 9 | ERN1 | 2.62446242 |
| 10 | BLK | 2.42165028 |
| 11 | IRAK4 | 2.39034087 |
| 12 | TBK1 | 2.35903832 |
| 13 | CSK | 2.31071297 |
| 14 | JAK1 | 2.22725662 |
| 15 | FGFR4 | 2.15274962 |
| 16 | KIT | 2.01463317 |
| 17 | ZAP70 | 2.00403247 |
| 18 | FES | 1.98521425 |
| 19 | GRK7 | 1.82674471 |
| 20 | IRAK3 | 1.71023282 |
| 21 | MAP3K13 | 1.70987301 |
| 22 | SYK | 1.67085427 |
| 23 | IKBKB | 1.65767563 |
| 24 | MAP2K3 | 1.60938210 |
| 25 | MATK | 1.59034405 |
| 26 | FGR | 1.53606261 |
| 27 | BTK | 1.53219876 |
| 28 | RIPK1 | 1.51556461 |
| 29 | MAP3K11 | 1.47820049 |
| 30 | CDC42BPA | 1.43638393 |
| 31 | JAK2 | 1.36074003 |
| 32 | FGFR3 | 1.35851567 |
| 33 | LYN | 1.35557602 |
| 34 | TAOK3 | 1.31367669 |
| 35 | TNK2 | 1.29241376 |
| 36 | EPHB1 | 1.29144808 |
| 37 | LCK | 1.29056493 |
| 38 | HCK | 1.28148011 |
| 39 | MAP3K3 | 1.25687412 |
| 40 | GRK6 | 1.25672650 |
| 41 | TAOK2 | 1.24321988 |
| 42 | TGFBR2 | 1.22797707 |
| 43 | BMPR2 | 1.18548445 |
| 44 | ITK | 1.14076800 |
| 45 | CSF1R | 1.13385098 |
| 46 | SIK3 | 1.08411926 |
| 47 | TAOK1 | 1.07990241 |
| 48 | EPHA3 | 1.05208410 |
| 49 | MAP3K1 | 1.02405920 |
| 50 | MARK3 | 0.96482265 |
| 51 | TESK2 | 0.95962944 |
| 52 | TEC | 0.93807611 |
| 53 | IRAK1 | 0.82984237 |
| 54 | HIPK2 | 0.80200463 |
| 55 | DDR2 | 0.79945574 |
| 56 | CHUK | 0.74067212 |
| 57 | STK10 | 0.68062162 |
| 58 | MAPK7 | 0.67668154 |
| 59 | ADRBK2 | 0.67357020 |
| 60 | MAPK11 | 0.66290986 |
| 61 | NLK | 0.65843369 |
| 62 | CAMKK2 | 0.65675457 |
| 63 | NME2 | 0.63618189 |
| 64 | TRIB3 | 0.62996044 |
| 65 | PIM1 | 0.62896955 |
| 66 | PDK1 | 0.59170418 |
| 67 | KDR | 0.54702126 |
| 68 | PRKCQ | 0.51309333 |
| 69 | MAPK12 | 0.50576793 |
| 70 | MARK2 | 0.49343404 |
| 71 | PDPK1 | 0.48610258 |
| 72 | FYN | 0.47289350 |
| 73 | CDK4 | 0.45635996 |
| 74 | MAP3K5 | 0.45494444 |
| 75 | MOS | 0.45454245 |
| 76 | LRRK2 | 0.45301423 |
| 77 | PRKD2 | 0.43878702 |
| 78 | SIK1 | 0.43672740 |
| 79 | SIK2 | 0.41056975 |
| 80 | CDK6 | 0.37699367 |
| 81 | IRAK2 | 0.37096797 |
| 82 | MAPK4 | 0.36137456 |
| 83 | MAP2K6 | 0.35787277 |
| 84 | RPS6KC1 | 0.35407438 |
| 85 | RPS6KL1 | 0.35407438 |
| 86 | CAMKK1 | 0.35277574 |
| 87 | MAPKAPK2 | 0.35219672 |
| 88 | PIK3CG | 0.32835944 |
| 89 | MAP3K7 | 0.32625158 |
| 90 | ABL1 | 0.32398024 |
| 91 | CLK1 | 0.30975668 |
| 92 | YES1 | 0.30316224 |
| 93 | PIM2 | 0.30312750 |
| 94 | MAP3K6 | 0.30115859 |
| 95 | TTN | 0.28413071 |
| 96 | MAP2K2 | 0.28366691 |
| 97 | PTK6 | 0.28260428 |
| 98 | RPS6KA6 | 0.28121842 |
| 99 | EGFR | 0.27949051 |
| 100 | TYRO3 | 0.27340372 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.58204561 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.20213193 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.17711325 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.12524070 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.86635981 |
| 6 | Asthma_Homo sapiens_hsa05310 | 2.73302351 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.65998625 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.57442157 |
| 9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.55635725 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.53199812 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.52242747 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.46402283 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.27444491 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.14197525 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.08245056 |
| 16 | Viral myocarditis_Homo sapiens_hsa05416 | 1.89966153 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.85794650 |
| 18 | Measles_Homo sapiens_hsa05162 | 1.84451890 |
| 19 | Influenza A_Homo sapiens_hsa05164 | 1.81007049 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.77260612 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.75540045 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.73839279 |
| 23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.70872273 |
| 24 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.70416192 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.64846673 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.64220529 |
| 27 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.63816793 |
| 28 | Pertussis_Homo sapiens_hsa05133 | 1.63488113 |
| 29 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.60672712 |
| 30 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.58282316 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.57552665 |
| 32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.45521066 |
| 33 | Other glycan degradation_Homo sapiens_hsa00511 | 1.44369310 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.43095043 |
| 35 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.38994218 |
| 36 | Legionellosis_Homo sapiens_hsa05134 | 1.29010207 |
| 37 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.28501299 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.22056137 |
| 39 | Hepatitis C_Homo sapiens_hsa05160 | 1.21325159 |
| 40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.13328501 |
| 41 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.12789241 |
| 42 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.05464089 |
| 43 | Phagosome_Homo sapiens_hsa04145 | 1.03697454 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.00607393 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.99790293 |
| 46 | Lysosome_Homo sapiens_hsa04142 | 0.98257052 |
| 47 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.89177751 |
| 48 | Apoptosis_Homo sapiens_hsa04210 | 0.87796474 |
| 49 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.81764421 |
| 50 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.81547019 |
| 51 | Salmonella infection_Homo sapiens_hsa05132 | 0.76374819 |
| 52 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.74256940 |
| 53 | Shigellosis_Homo sapiens_hsa05131 | 0.74039924 |
| 54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.73057220 |
| 55 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.67664477 |
| 56 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.62726277 |
| 57 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.62318562 |
| 58 | Platelet activation_Homo sapiens_hsa04611 | 0.58776271 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.55405766 |
| 60 | HTLV-I infection_Homo sapiens_hsa05166 | 0.52957949 |
| 61 | Prion diseases_Homo sapiens_hsa05020 | 0.50441548 |
| 62 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47787226 |
| 63 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.47302335 |
| 64 | Amoebiasis_Homo sapiens_hsa05146 | 0.47274784 |
| 65 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46185710 |
| 66 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.45462789 |
| 67 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.45208947 |
| 68 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.42853771 |
| 69 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.41551171 |
| 70 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.40846497 |
| 71 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.40663547 |
| 72 | Insulin resistance_Homo sapiens_hsa04931 | 0.40481289 |
| 73 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.36879739 |
| 74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.36471651 |
| 75 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.35957897 |
| 76 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.32783008 |
| 77 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.32617223 |
| 78 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.30231218 |
| 79 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.30042259 |
| 80 | Endocytosis_Homo sapiens_hsa04144 | 0.29358521 |
| 81 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.28518211 |
| 82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.28491526 |
| 83 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.26017482 |
| 84 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.24924691 |
| 85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.24586955 |
| 86 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.24190345 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.22906942 |
| 88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.19677698 |
| 89 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.19532274 |
| 90 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.19163937 |
| 91 | ABC transporters_Homo sapiens_hsa02010 | 0.18843199 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.17696398 |
| 93 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.17236768 |
| 94 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.15930463 |
| 95 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.15847162 |
| 96 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.15829079 |
| 97 | Bladder cancer_Homo sapiens_hsa05219 | 0.14916212 |
| 98 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.14185053 |
| 99 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.13912241 |
| 100 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.13015615 |

